Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03393611 | CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome | ||
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT03485729 | ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer | ||
| NCT03335267 | Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia | ||
| NCT03134131 | Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas | ||
| NCT01323569 | Abuse Potential of Sativex | ||
| NCT03555955 | A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 | ||
| NCT01843634 | Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia | ||
| NCT02325011 | An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. | ||
| NCT03339401 | The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation | ||
| NCT01426295 | Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital | ||
| NCT05869773 | A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy | ||
| NCT00711646 | A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis. | ||
| NCT07192068 | Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. | ||
| NCT02863991 | Oral ONC201 in Relapsed/Refractory Multiple Myeloma | ||
| NCT05392374 | Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT04291937 | A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA | ||
| NCT04176042 | Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea | ||
| NCT00594256 | Sodium Oxybate in Schizophrenia With Insomnia | ||
| NCT02647190 | Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | ||
| NCT03416530 | ONC201 in Pediatric H3 K27M Gliomas | ||
| NCT07278505 | Study of Cannabidiol and Neuroimaging on Stress | ||
| NCT01401140 | Comparing the Protective Effects of Two Cardioplegic Solutions, on Cardiac Metabolism, as Assessed Using Microdialysis | ||
| NCT01681121 | A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy | ||
| NCT05055271 | Delphi Consensus Excessive Daytime Sleepiness in OSA | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT01337089 | Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain | ||
| NCT01696084 | Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia | ||
| NCT04578444 | An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer | ||
| NCT01943682 | Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma | ||
| NCT06182410 | Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma | ||
| NCT06738368 | Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia | ||
| NCT05229588 | Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations | ||
| NCT00423813 | A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. | ||
| NCT04990102 | Phase IB/II of CPX-351 for Relapse Prevention in AML | ||
| NCT05642442 | A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's Disease | ||
| NCT04252586 | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | ||
| NCT02892123 | Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers | ||
| NCT00361842 | Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer | ||
| NCT03865589 | Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome | ||
| NCT05485831 | Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY | ||
| NCT06261502 | Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome | ||
| NCT04652115 | Defibrotide for the Treatment of Severe COVID-19 | ||
| NCT00106860 | A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder | ||
| NCT04610658 | Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC | ||
| NCT04038437 | A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML | ||
| NCT03878199 | Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms |
